Cardiovascular Events in Patients taking Varenicline: A Case Series from Intensive Postmarketing Surveillance in New Zealand

Author： Harrison-Woolrych Mira  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.35, Iss.1, 2012-01, pp. : 33-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib: Interim Results from the New Zealand Intensive Medicines Monitoring Programme

By Harrison-Woolrych Mira  

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 435-442

Adis International

Access to resources Recommend Favorite

Psychiatric Adverse Events Associated with Varenicline: An Intensive Postmarketing Prospective Cohort Study in New Zealand

By Harrison-Woolrych Mira   Ashton Janelle  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 763-772

Adis International

Access to resources Recommend Favorite

Varenicline and CV events: postmarketing experience in NZ

By  

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance: An Overview from India

By Hegde Sanath   Gogtay Nithya J.   Kshirsagar Nilima A.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 3, 2005-01 ,pp. : 141-151

Adis International

Access to resources Recommend Favorite

Link between varenicline and cardiovascular events questioned

By  

Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite